461030 — IMBDX Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapSucker Stock

Annual income statement for IMBDX, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	PROSPECTUS	PROSPECTUS	ARS	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	157	1,230	2,625	4,027	3,407
Cost of Revenue
Gross Profit	130	31.6	372	1,417	888
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	2,622	6,496	11,292	11,796	14,019
Operating Profit	-2,465	-5,265	-8,668	-7,769	-10,612
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-11,067	-9,789	-10,436	-10,416	-9,577
Provision for Income Taxes
Net Income After Taxes	-11,067	-9,789	-10,436	-10,416	-9,577
Net Income Before Extraordinary Items
Net Income	-11,067	-9,789	-10,436	-10,416	-9,577
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-11,067	-9,789	-10,436	-10,416	-9,577
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-791	-700	-746	-744	-715
Dividends per Share